|1 Table of Contents 3
|1.1 List of Tables 10
|1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Oncology Market Segmentation 14
2.3 Definitions of Markets Covered in the Report 16
3 Oncology Market, EU5 23
3.1 Oncology Market, EU5, Revenue ($m), 2018-2033 23
3.2 Oncology Market, EU5, Revenue ($m), 2018-2033 25
3.3 Oncology Market, EU5, Volume (Units), 2018-2033 28
3.4 Oncology Market, EU5, Volume (Units), 2018-2033 30
3.5 Oncology Market, EU5, Company Share by Revenue ($m), 2024 33
4 Oncology Market, France 35
4.1 Oncology Market, France, Revenue ($m), 2018-2033 35
4.1.1 ALK Tests Market, France, Revenue ($m), by Segment, 2018-2033 38
4.1.2 BCR-ABL Tests Market, France, Revenue ($m), by Segment, 2018-2033 40
4.1.3 BRAF Tests Market, France, Revenue ($m), by Segment, 2018-2033 42
4.1.4 BRCA Tests Market, France, Revenue ($m), by Segment, 2018-2033 44
4.1.5 Colorectal Cancer Screening Tests Market, France, Revenue ($m), by Segment, 2018-2033 46
4.1.6 EGFR Tests Market, France, Revenue ($m), by Segment, 2018-2033 48
4.1.7 HER2 Tests Market, France, Revenue ($m), by Segment, 2018-2033 50
4.1.8 KRAS Tests Market, France, Revenue ($m), by Segment, 2018-2033 52
4.2 Oncology Market, France, Volume (Units), 2018-2033 54
4.2.1 ALK Tests Market, France, Volume (Units), by Segment, 2018-2033 57
4.2.2 BCR-ABL Tests Market, France, Volume (Units), by Segment, 2018-2033 59
4.2.3 BRAF Tests Market, France, Volume (Units), by Segment, 2018-2033 61
4.2.4 BRCA Tests Market, France, Volume (Units), by Segment, 2018-2033 63
4.2.5 Colorectal Cancer Screening Tests Market, France, Volume (Units), by Segment, 2018-2033 65
4.2.6 EGFR Tests Market, France, Volume (Units), by Segment, 2018-2033 67
4.2.7 HER2 Tests Market, France, Volume (Units), by Segment, 2018-2033 69
4.2.8 KRAS Tests Market, France, Volume (Units), by Segment, 2018-2033 71
4.3 Oncology Market, France, Average Price ($) , 2018-2033 73
4.4 Oncology Market, France, Company Share by Revenue ($m), 2024 77
5 Oncology Market, Germany 79
5.1 Oncology Market, Germany, Revenue ($m), 2018-2033 79
5.1.1 ALK Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 82
5.1.2 BCR-ABL Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 84
5.1.3 BRAF Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 86
5.1.4 BRCA Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 88
5.1.5 Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 90
5.1.6 EGFR Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 92
5.1.7 HER2 Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 94
5.1.8 KRAS Tests Market, Germany, Revenue ($m), by Segment, 2018-2033 96
5.2 Oncology Market, Germany, Volume (Units), 2018-2033 98
5.2.1 ALK Tests Market, Germany, Volume (Units), by Segment, 2018-2033 101
5.2.2 BCR-ABL Tests Market, Germany, Volume (Units), by Segment, 2018-2033 103
5.2.3 BRAF Tests Market, Germany, Volume (Units), by Segment, 2018-2033 105
5.2.4 BRCA Tests Market, Germany, Volume (Units), by Segment, 2018-2033 107
5.2.5 Colorectal Cancer Screening Tests Market, Germany, Volume (Units), by Segment, 2018-2033 109
5.2.6 EGFR Tests Market, Germany, Volume (Units), by Segment, 2018-2033 111
5.2.7 HER2 Tests Market, Germany, Volume (Units), by Segment, 2018-2033 113
5.2.8 KRAS Tests Market, Germany, Volume (Units), by Segment, 2018-2033 115
5.3 Oncology Market, Germany, Average Price ($) , 2018-2033 117
5.4 Oncology Market, Germany, Company Share by Revenue ($m), 2024 121
6 Oncology Market, Italy 123
6.1 Oncology Market, Italy, Revenue ($m), 2018-2033 123
6.1.1 ALK Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 126
6.1.2 BCR-ABL Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 128
6.1.3 BRAF Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 130
6.1.4 BRCA Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 132
6.1.5 Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 134
6.1.6 EGFR Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 136
6.1.7 HER2 Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 138
6.1.8 KRAS Tests Market, Italy, Revenue ($m), by Segment, 2018-2033 140
6.2 Oncology Market, Italy, Volume (Units), 2018-2033 142
6.2.1 ALK Tests Market, Italy, Volume (Units), by Segment, 2018-2033 145
6.2.2 BCR-ABL Tests Market, Italy, Volume (Units), by Segment, 2018-2033 147
6.2.3 BRAF Tests Market, Italy, Volume (Units), by Segment, 2018-2033 149
6.2.4 BRCA Tests Market, Italy, Volume (Units), by Segment, 2018-2033 151
6.2.5 Colorectal Cancer Screening Tests Market, Italy, Volume (Units), by Segment, 2018-2033 153
6.2.6 EGFR Tests Market, Italy, Volume (Units), by Segment, 2018-2033 155
6.2.7 HER2 Tests Market, Italy, Volume (Units), by Segment, 2018-2033 157
6.2.8 KRAS Tests Market, Italy, Volume (Units), by Segment, 2018-2033 159
6.3 Oncology Market, Italy, Average Price ($) , 2018-2033 161
6.4 Oncology Market, Italy, Company Share by Revenue ($m), 2024 164
7 Oncology Market, Spain 166
7.1 Oncology Market, Spain, Revenue ($m), 2018-2033 166
7.1.1 ALK Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 169
7.1.2 BCR-ABL Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 171
7.1.3 BRAF Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 173
7.1.4 BRCA Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 175
7.1.5 Colorectal Cancer Screening Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 177
7.1.6 EGFR Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 179
7.1.7 HER2 Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 181
7.1.8 KRAS Tests Market, Spain, Revenue ($m), by Segment, 2018-2033 183
7.2 Oncology Market, Spain, Volume (Units), 2018-2033 185
7.2.1 ALK Tests Market, Spain, Volume (Units), by Segment, 2018-2033 188
7.2.2 BCR-ABL Tests Market, Spain, Volume (Units), by Segment, 2018-2033 190
7.2.3 BRAF Tests Market, Spain, Volume (Units), by Segment, 2018-2033 192
7.2.4 BRCA Tests Market, Spain, Volume (Units), by Segment, 2018-2033 194
7.2.5 Colorectal Cancer Screening Tests Market, Spain, Volume (Units), by Segment, 2018-2033 196
7.2.6 EGFR Tests Market, Spain, Volume (Units), by Segment, 2018-2033 198
7.2.7 HER2 Tests Market, Spain, Volume (Units), by Segment, 2018-2033 200
7.2.8 KRAS Tests Market, Spain, Volume (Units), by Segment, 2018-2033 202
7.3 Oncology Market, Spain, Average Price ($) , 2018-2033 204
7.4 Oncology Market, Spain, Company Share by Revenue ($m), 2024 207
8 Oncology Market, United Kingdom 209
8.1 Oncology Market, United Kingdom, Revenue ($m), 2018-2033 209
8.1.1 ALK Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 212
8.1.2 BCR-ABL Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 214
8.1.3 BRAF Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 216
8.1.4 BRCA Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 218
8.1.5 Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 220
8.1.6 EGFR Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 222
8.1.7 HER2 Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 224
8.1.8 KRAS Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 226
8.2 Oncology Market, United Kingdom, Volume (Units), 2018-2033 228
8.2.1 ALK Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 231
8.2.2 BCR-ABL Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 233
8.2.3 BRAF Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 235
8.2.4 BRCA Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 237
8.2.5 Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 239
8.2.6 EGFR Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 241
8.2.7 HER2 Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 243
8.2.8 KRAS Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033 245
8.3 Oncology Market, United Kingdom, Average Price ($) , 2018-2033 247
8.4 Oncology Market, United Kingdom, Company Share by Revenue ($m), 2024 251
9 Overview of Key Companies in EU5, Oncology Market 253
9.1 F. Hoffmann-La Roche Ltd 253
9.1.1 Company Overview 253
9.2 Agilent Technologies Inc 253
9.2.1 Company Overview 253
9.3 Qiagen NV 253
9.3.1 Company Overview 253
9.4 Abbott Laboratories 253
9.4.1 Company Overview 253
9.5 Danaher Corp 254
9.5.1 Company Overview 254
9.6 Eiken Chemical Co Ltd 254
9.6.1 Company Overview 254
9.7 SENTINEL CH SpA 254
9.7.1 Company Overview 254
9.8 Hemosure Inc 254
9.8.1 Company Overview 254
9.9 Resonac Corporation 255
9.9.1 Company Overview 255
10 Recent Developments 257
10.1 Corporate Communications 257
10.1.1 Jun 24, 2025: GSK Announces Director Declaration 257
10.1.2 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer 257
10.1.3 Feb 11, 2025: UK-backed AI Companies to Transform British Cancer Care and Spark New Drug Breakthroughs 258
10.1.4 Oct 10, 2024: Inify Laboratories gets honorable mention by the Royal Swedish Academy of Engineering Sciences (IVA) at the Smart Industry business competition 2024 259
10.1.5 Oct 09, 2024: New Hub to Develop Advanced Cancer Imaging Techniques 260
10.1.6 Oct 07, 2024: UK Government greenlights £146m tech package to tackle cancer 260
10.1.7 Oct 03, 2024: Successful 2024 ISO 13485 Certification Maintenance Strengthening Ikonisys’ Strong Market Position and Growth Potential 261
10.1.8 Sep 10, 2024: Tyra Biosciences Appoints Doug Warner as Chief Medical Officer 261
10.1.9 Sep 09, 2024: NIHR Announces New Funding Opportunities for Novel Brain Tumour Research Launched 262
10.2 Financial Announcements 263
10.2.1 Apr 09, 2025: Newbury Pharmaceuticals Releases Interim Report September 2024 – February 2025 263
10.2.2 Jan 16, 2025: Devyser Publishes Preliminary Result for Q4 2024 263
10.2.3 Nov 12, 2024: Immunovia’s Invitation for Q3 Presentation 264
10.2.4 Nov 06, 2024: BerGenBio ASA: Invitation to Third Quarter 2024 Results Webcast 264
10.2.5 Oct 23, 2024: Newbury Pharmaceuticals Year-End Report September 2023 – August 2024 264
10.2.6 Aug 06, 2024: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance 265
10.2.7 Aug 05, 2024: Immunovia Publishes Interim Report for January-June 2024 266
10.3 Government and Public Interest 268
10.3.1 May 20, 2025: The Discovery That Transformed Prostate Cancer Radiotherapy 268
10.3.2 Apr 23, 2025: CRUK Funding for Research Into Earlier Detection of Relapse in People With Multiple Myeloma 270
10.3.3 Apr 14, 2025: Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals in the EU 270
10.3.4 Nov 11, 2024: Nordic Bioscience Receives Letter of Support from the FDA for the CPa9-HNE Biomarker in Inflammatory Bowel Diseases 270
10.3.5 Nov 05, 2024: UK to Create World-First ‘Early Warning System’ for Pandemics 271
10.4 Legal And Regulatory 272
10.4.1 Dec 04, 2024: MHRA trials five innovative AI Technologies as Part of Pilot Scheme to Change Regulatory Approach 272
10.5 Other Significant Developments 274
10.5.1 Jun 23, 2025: Icon Group and Varian Expand Global Partnership To Deliver Advanced Cancer Technology Across the UK 274
10.5.2 May 19, 2025: Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology 275
10.5.3 May 02, 2025: NHS Forth Valley Launches New Rapid Cancer Diagnostic Service 275
10.5.4 Apr 24, 2025: Stellaromics Announces First Deployment of Pyxa Platform in Europe 276
10.5.5 Mar 25, 2025: Diagnostic Capacity Increased with Installation of New CT Scanner 276
10.5.6 Mar 10, 2025: Longevity Life Advisors Launches CancerEDGE: A Program Offering Advanced Cancer Genomics and Precision Health Services 277
10.5.7 Mar 05, 2025: Atrys Chile and Interclínica Launch a New Telemedicine-Based Care Model to Reduce Stroke Response Time 277
10.5.8 Feb 14, 2025: Bio-Works Technologies Doubles Production Capacity To Meet Growing Demand 278
10.5.9 Feb 11, 2025: Alcidion Receives Contract With Hywel Dda University Health Board in Wales 278
10.5.10 Feb 05, 2025: Development of Innovative, High Value-Added Oncological Drug Products for Personalized Therapies 278
10.5.11 Jan 20, 2025: New Screening Tool for the Assessment of Cognitive Symptoms in Patients with Cancer 279
10.5.12 Jan 14, 2025: Enea TECH and Biomedical Foundation invests €15 Million in Tethis to Develop New Diagnostic Methods in Oncology Using Liquid Biopsy 279
10.5.13 Jan 06, 2025: PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development 280
10.5.14 Dec 20, 2024: Atrys Health Reduces Medical Care Times in Chile by 88% Thanks to Telemedicine and AI 281
10.5.15 Dec 17, 2024: Diaceutics Wins New $5.1m Contract 281
10.5.16 Dec 16, 2024: Immunovia to Host a Webcast with the Opportunity to Learn More about the Positive Clinical Validation of Its Next-Generation Pancreatic Cancer Test 282
10.5.17 Dec 06, 2024: RayStation in clinical use for proton arc therapy at the Trento Proton Therapy Center 282
10.5.18 Dec 03, 2024: Capitainer Participates in Global AI Project for Advanced Lung Diagnostics 282
10.5.19 Nov 29, 2024: NHS calls for women to attend routine cervical screenings 283
10.5.20 Nov 12, 2024: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Technology in Oncological Diagnostics and Organ Transplant Safety 283
10.5.21 Oct 31, 2024: CURE51 Chooses 10X Genomics Visium HD for New Drug Discovery Initiative 284
10.5.22 Oct 19, 2024: Institute of Cancer Research : £1.5m AI and Genetics Project to Find Men with Deadliest Prostate Cancers Early 284
10.5.23 Oct 09, 2024: Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten Test 285
10.5.24 Sep 24, 2024: Prostate cancer breakthrough: Novigenix-led project receives €1.75M grant to improve patient outcomes using liquid biopsy technology 286
10.5.25 Sep 17, 2024: Precision Microbiome Profiling Demonstrates It Diagnostic Potential in Groundbreaking Work Conducted at Gustave Roussy Cancer Institute 287
10.5.26 Sep 11, 2024: Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands 287
10.5.27 Sep 02, 2024: EDX Medical partners with Caris Life Sciences for molecular profiling 288
10.5.28 Aug 21, 2024: INIFY Laboratories: 62% Revenue Growth and Strong International Interest 288
10.5.29 Aug 20, 2024: Dr.Tanya Stoyanova Receives Grant to Develop New Radiopharmaceuticals for Cancer 289
10.5.30 Jul 26, 2024: Commission Approves €2 Billion Dutch Measure to Support Production of Medical Radioisotopes for Cancer Diagnosis and Treatment 289
10.5.31 Jul 09, 2024: New Co-Star Receptor Shows Promise Treating Cancers in Laboratory Study 290
10.5.32 Jul 02, 2024: Immunovia’s New Lab Staffed and Operational After Rapid Implementation 291
10.6 Product News 291
10.6.1 Jun 19, 2025: A Technology That Detects Breast Cancer Relapses up to Five Years in Advance Has Been Developed 291
10.6.2 Jun 18, 2025: Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy 292
10.6.3 Jun 12, 2025: Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences 292
10.6.4 Jun 02, 2025: Using Artificial Intelligence to Detect Changes in Lung Tumors with Greater Speed and Precision 293
10.6.5 May 30, 2025: NHS First in World to Roll Out ‘Revolutionary’ Blood Test for Cancer Patients 293
10.6.6 May 28, 2025: Supplemental Breast Cancer Imaging Techniques Could Lead to Earlier Detection of Cancer in Women with Dense Breasts 295
10.6.7 May 21, 2025: Lexogen Launches miRVEL Discovery – Cutting-edge Small RNA-Seq Library Prep Kit for sRNA Discovery and Biomarker studies 296
10.6.8 May 19, 2025: First NKI Early Cancer Detection Conference Turns Out a Success 296
10.6.9 May 07, 2025: Clariti Study Featured in Best of Digestive Disease Week 297
10.6.10 Apr 11, 2025: Transforming Cervical Cancer Screening: Dr Mariana Costa's Insights From EUROGIN 2024 297
10.6.11 Apr 08, 2025: Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM 298
10.6.12 Mar 25, 2025: Diagnostic Capacity Increased with Installation of New CT Scanner 299
10.6.13 Mar 24, 2025: Research Shows Importance of Genomic Testing and Targeted Therapies for Advanced Cancers 299
10.6.14 Mar 14, 2025: Bioemtech : EMIM 2025 @Bilbao, Spain 300
10.6.15 Mar 10, 2025: Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk of Survival Events Over Time Between Young BRCA1/2 Carriers 300
10.6.16 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer 301
10.6.17 Feb 14, 2025: New Patent Approval in China Strengthens the AroCell Patent Portfolio 302
10.6.18 Feb 06, 2025: Researchers Develop a Device That Replicates Tumours to Study the Efficacy of Immunotherapy Treatments 302
10.6.19 Feb 03, 2025: New Screening Device Shows Promise for Early Lung Cancer Detection 303
10.6.20 Jan 27, 2025: Ikonisys Secures U.S. Patent for “Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments” 303
10.6.21 Jan 24, 2025: JNM Publishes Procedure Standard/Practice Guideline for Fibroblast Activation Protein PET 304
10.6.22 Jan 20, 2025: Biomarkers in Immuno-Oncology: Identifying and Implementing Biomarker Testing From Exploratory Research to Clinical Trials 305
10.6.23 Jan 17, 2025: Genetic Testing for Lynch Syndrome Prevents Cancers Being Missed 305
10.6.24 Jan 14, 2025: Panakeia Announces Launch of PANProfiler Colon 306
10.6.25 Jan 09, 2025: New ‘Explant’ Technique Predicts a Tumour’s Responsiveness to Breast Cancer Treatment 306
10.6.26 Dec 18, 2024: Clarity Announces Expansion of Pipeline With Novel Optimised FAP-Targeted Radiopharmaceutical 307
10.6.27 Dec 18, 2024: BioView Presents Promising Results from Their Joint Liquid Biopsy Development Project 308
10.6.28 Dec 10, 2024: New Understanding of Aggressive Form of Breast Cancer Paves the Way for Tests and Treatments 309
10.6.29 Dec 03, 2024: The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC” 310
10.6.30 Nov 28, 2024: VU Researchers Develop Research Equipment to Identify Contaminants in Water 310
10.6.31 Nov 21, 2024: Researchers Identify Inflammatory Markers Related to the Prognosis of Breast Cancer 311
10.6.32 Nov 21, 2024: Prestigious Cancer Center Institut Curie Introduces Ibex Medical Analytics’ AI Tools for Cancer Diagnostics 311
10.6.33 Nov 19, 2024: WWL Launches New AI Solution to Diagnose Lung Cancer Quicker 312
10.6.34 Nov 12, 2024: Researchers Identify a Potential Biomarker of Parkinson’s Disease Progression 314
10.6.35 Nov 11, 2024: Report Published by Research Journal, Germany’s Springer Concluded that TruScreen Cervical Cancer Screening Results were Comparable and Better than conventional LBC 315
10.6.36 Nov 07, 2024: Nec and Nec Bio Publish Foundational Work on T Cell Receptor Engineering Using Proprietary Generative AI at the Society for Immunotherapy of Cancer Annual Meeting 316
10.6.37 Nov 07, 2024: Immunovia Presents Data From Model Development Study at Meeting of the Precede Pancreatic Cancer Research Consortium 317
10.6.38 Nov 06, 2024: Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics 317
10.6.39 Nov 02, 2024: New iPhone Device to Help Rule out Throat Cancer 318
10.6.40 Oct 25, 2024: Scientists Identify Biomarkers in Semen Samples That Could Help Reduce Overdiagnosis in Prostate Cancer Screening 319
10.6.41 Oct 17, 2024: Medigene Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024 319
10.6.42 Oct 17, 2024: Renovarocube Presents Novel Insights on Non-invasive Cancer Diagnostics Using Oxford Nanopore Sequencing 320
10.6.43 Oct 06, 2024: New Government Tech Deals Boost the Business of Cancer Detection 320
10.6.44 Oct 04, 2024: Medical Imaging Breakthrough Could Transform Cancer and Arthritis Diagnosis 323
10.6.45 Sep 30, 2024: New Genetic Testing Pathways Could Ensure Patients Get Personalised Treatments and Help to Catch More BRCA-Linked Cancer Cases 324
10.6.46 Sep 26, 2024: Takara Bio Europe Unveils New Large-Scale NGS Profiling System and Chemistries 325
10.6.47 Sep 17, 2024: The Results Of a Test Created In Barcelona For The Detection Of Multiple Cancers Are Presented at ESMO 326
10.6.48 Sep 15, 2024: Imperial Startups Changing the World one Tech at a Time 326
10.6.49 Sep 14, 2024: SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 328
10.6.50 Sep 09, 2024: Oxford Nanopore Announces Participation in the Progress Study, With Yemaachi Biotech 329
10.6.51 Aug 26, 2024: Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors 330
10.6.52 Aug 21, 2024: Breakthrough for Cancer Patients as a Network of Digitised NHS Pathology Departments Is Now Live in the North of England 330
10.6.53 Aug 19, 2024: Diaceutics Announces Launch of PMx 331
10.6.54 Aug 02, 2024: Immunovia Files Us Patent Application to Protect Its Next-Generation Test 332
10.6.55 Aug 01, 2024: Development of a Method to Predict Onset of Non-Alcoholic Fatty Liver Disease —Contributing to Preventive Healthcare for Lifestyle Diseases 332
10.6.56 Jul 30, 2024: NHS Forth Valley : Plans for Third CT Scanner Approved 333
10.6.57 Jul 29, 2024: Groundbreaking Vine Robots with Magnetic Skin Could Transform Cancer Treatment 334
10.6.58 Jul 25, 2024: Researchers Identify Cheap and Effective Biomarkers for DCIS Tumor Stage 335
10.6.59 Jul 23, 2024: Artificial Intelligence Predicts Recurrence Years Ahead 336
10.6.60 Jul 22, 2024: Accelerating Genomics through Automated RNA Sequencing 336
10.6.61 Jul 15, 2024: A New Biomarker Shows Potential to Evaluate Treatment Response for Metastatic Colorectal Cancer 337
10.6.62 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer 338
10.6.63 Jul 12, 2024: A New Bioinformatics Algorithm Improves the Genetic Detection of Lynch and CMMRD Syndromes 339
10.6.64 Jul 10, 2024: New Method of Measuring Tumour Infiltrating Lymphocytes Predicts Long Term Outcomes for a Type of early Breast Cancer 339
10.6.65 Jul 09, 2024: Breakthrough AI Method to Select Women for MRI Enhances Breast Cancer Detection and Outperforms Traditional Methods in Landmark Study 339
10.6.66 Jul 09, 2024: Prostate Cancer Spreads by Sending Messages to Other Organs 340
10.6.67 Jul 04, 2024: A Genetic Test Will Improve the Diagnosis of a Rare Cancer Predisposition Syndrome in Children 341
10.7 Research And Development 341
10.7.1 Nov 05, 2024: Inify Laboratories Enter a Research Partnership With the Department of Molecular Medicine and Surgery at Karolinska Institutet Aiming to Advance Precision Diagnostics Within Prostate Cancer 341
10.7.2 Jul 24, 2024: Research Study Aims to Detect Lung Cancer Earlier via Simple Test 342
10.8 Strategy And Business Planning 343
10.8.1 Jun 30, 2025: Affidea Group Selects b-rayZ as Its Preferred AI Partner in Breast Imaging, Marking Strategic Collaboration 343
10.8.2 Jun 26, 2025: Inify Laboratories Deliver Diagnostics for Its First Patient Case in the UK in Collaboration With Parkside Frimley 343
10.8.3 May 30, 2025: Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research 344
10.8.4 May 28, 2025: Novellia Launches AI-Powered, Cross-Industry Research Initiative to Transform Breast Cancer Care 345
10.8.5 May 28, 2025: Topping-Out Ceremony for Our New Production Laboratory 345
10.8.6 May 27, 2025: The Royal Marsden NHS Foundation Trust Announces Partnership With NTT DATA and CARPL.ai 346
10.8.7 May 23, 2025: Qiagen and ID Solutions collaborate on dPCR assays for oncology research 346
10.8.8 May 15, 2025: N4 Pharma : Change of Registered Address 347
10.8.9 May 06, 2025: Volta Labs and Hartwig Medical Foundation Announce Multi-Year Collaboration 347
10.8.10 May 06, 2025: Volta Labs And Hartwig Medical Foundation Collaborate to Advance Oncological Discoveries With the Callisto Sample Prep System 348
10.8.11 Apr 30, 2025: Inify Laboratories: Continued Strong Growth – Construction and Establishment in the UK 348
10.8.12 Apr 22, 2025: Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs 349
10.8.13 Apr 22, 2025: ConcertAI Signs Strategic Agreement With Bayer 349
10.8.14 Apr 04, 2025: Google Cloud and Ai2 Announce Partnership With Cancer AI Alliance 350
10.8.15 Mar 25, 2025: GE Healthcare and Swiss Medical Network Sign Master Research Agreement 351
10.8.16 Mar 24, 2025: Philips Announces Expansion of Partnership With Ibex Medical Analytics 352
10.8.17 Mar 10, 2025: Biovica Inks New Work Order With US Biotech Company for TKa Testing Services 353
10.8.18 Mar 06, 2025: Top-rated US Health System Expands Sectra’s Enterprise Imaging Solution with Digital Pathology to Enhance Collaboration for Improved Cancer Care 353
10.8.19 Mar 04, 2025: Tower Health, Siemens Healthineers Launch 10-Year Value Partnership to Advance Precision Imaging and Patient Care 353
10.8.20 Feb 27, 2025: Meditech Expanse Genomics and GenomOncology Integration Drives Targeted Cancer Treatments at Frederick Health 354
10.8.21 Feb 26, 2025: OncoHost Announces Collaboration With Gustave Roussy 355
10.8.22 Feb 11, 2025: Large Swedish Healthcare Region Expands Use of Sectra’s Solution With Digital Pathology to Enhance Cancer Diagnostics 355
10.8.23 Feb 10, 2025: Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis 356
10.8.24 Feb 06, 2025: Paige Expands Single AI Application to Detect Common, Rare Variants, and Precursor Lesions to Cancer Across More Than 40 Organs and Tissues 357
10.8.25 Jan 08, 2025: Inify Laboratories Enter Into Agreement with Swedish Region 357
10.8.26 Jan 06, 2025: PhenoVista Biosciences Partners with NETRI to Expand Organ-on-Chip Service Offerings for Drug Development 357
10.8.27 Dec 12, 2024: Tracer Biotechnologies Announces Multi-Year Project With AstraZeneca 358
10.8.28 Dec 05, 2024: IVDR-Certified FISH Probe Portfolio Expands to 95 Probes 358
10.8.29 Nov 26, 2024: Oxford Nanopore Technologies Announces New Collaboration With UK Biobank 358
10.8.30 Nov 26, 2024: Siemens Healthineers and The Ohio State Wexner Medical Center Expand Existing Strategic Relationship 360
10.8.31 Nov 25, 2024: French Hospital Joins Regional Pathology Solution From Sectra to Enhance Collaboration and Speed Up Cancer Diagnostics 360
10.8.32 Nov 05, 2024: UK to Create World-First ‘Early Warning System’ for Pandemics 361
10.8.33 Sep 26, 2024: Lunaphore Partners with Discovery Life Sciences to Bring Innovative Spatial Biology Solutions to Clinical Research 362
10.8.34 Sep 24, 2024: Curium Opens Additional and New Facility in Petten, Netherlands 363
10.8.35 Sep 23, 2024: Angle PLC Announces Exclusive Agreement for DNA NGS Panel 363
10.8.36 Sep 19, 2024: PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics 364
10.8.37 Sep 16, 2024: New Collaboration to Introduce Liquid Biopsy Testing for Lung Cancer 365
10.8.38 Aug 19, 2024: Diaceutics Announces Launch of PMx 365
10.8.39 Jul 11, 2024: MGI Announces Collaboration With Predica Diagnostics 366
11 Appendix 368
11.1 Research Methodology 369
11.1.1 Coverage 369
11.1.2 Secondary Research 369
11.1.3 Primary Research 369
11.1.4 Market Modeling and Forecasting 370
11.1.5 Company Share Analysis 371
11.1.6 Benchmarking 372
11.2 GlobalData Consulting 373
11.3 Contact Us 373
11.4 Disclaimer 373
